Invited Speaker Series: Adam Wilkinson

Adam Wilkinson is a Krishnan-Ang Distinguished Scholar and Group Leader in the Department of Haematology and Cambridge Stem Cell Institute. After completing his undergraduate degree at the University of Oxford, he undertook PhD training at the University of Cambridge Department of Haematology with Professor Bertie Gottgens. He then performed postdoctoral training with Professor Hiromitsu Nakauchi at the University of Tokyo and Stanford University. He started his own lab in 2021 at the MRC Weatherall Institute of Molecular Medicine at the University of Oxford before moving back to Cambridge in spring 2025. During this time, he has pioneered new methods to expand transplantable haematopoietic stem cells (HSCs) long-term ex vivo (Wilkinson et al, Nature 2019; Igarashi et al, Blood Advances 2023; Sakurai et al, Nature 2023) and to evaluate the consequences of CRISPR/Cas9 gene editing on functional HSCs in transplantation models (Wilkinson et al, Nature Communications 2021; Becker et al, Cell Stem Cell 2023). The Wilkinson laboratory is currently leveraging this technology to (1) investigate the molecular regulation of HSC self-renewal and lineage commitment, (2) better understand how HSC dysfunction can drive blood cancer initiation, and (3) develop novel HSC-based therapies.

Location: Lecture Hall Krehl-Klinik, University Hospital Heidelberg INF 410 Heidelberg
Date: Tuesday October 14th; 4pm